The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}.
Trials
; 24(1): 770, 2023 Nov 28.
Article
in En
| MEDLINE
| ID: mdl-38017457
Full text:
1
Database:
MEDLINE
Main subject:
Amlodipine
/
Essential Hypertension
/
Antihypertensive Agents
Language:
En
Journal:
Trials
Year:
2023
Type:
Article